Personalis MRD Test Shows Superior Sensitivity in Lung Cancer Trial
The test demonstrated higher baseline sensitivity for ctDNA detection compared to gene mutation-based testing in AstraZeneca's NeoADAURA study.
The test demonstrated higher baseline sensitivity for ctDNA detection compared to gene mutation-based testing in AstraZeneca's NeoADAURA study.
A Rutgers research director outlines clinical applications and limitations of the new diagnostic tool while highlighting the need for specialist interpretation.
The Alzheimer's Association released its first clinical practice guideline on the use of blood-based biomarker tests.
Two new American Cancer Society studies reveal significant increases in colorectal cancer...
Clinical labs help drive early HIV detection and support efforts to prevent its spread.
The new noninvasive prenatal test addresses testing gaps when biological fathers are unavailable for carrier screening by analyzing fetal DNA from maternal blood samples.
New research demonstrates BAT outperforms standard allergy tests in children under 2, potentially reducing need for oral food challenges by nearly half.
Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.
ALZpath pTau217 antibody data was included in 37 submissions at AAIC, building on research demonstrating its sensitivity and accuracy in blood-based tests for Alzheimer's disease.
It's essential to integrate point-of-care testing devices cautiously alongside traditional laboratory tests to ensure robust diabetes management.
With the acquisition, Quest will now provide dialysis lab testing for independent clinics that were previously served by Spectra Laboratories.
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
A multicenter study found that early sepsis risk testing at triage led to more ED discharges and lower inpatient bed use without compromising patient safety.